Kenneth Erland Johnson Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Kenneth Erland Johnson is Officer of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 361,764 shares of XERS, which is worth approximately $1.29 Million. The most recent transaction as insider was on Jan 03, 2025, when has been sold 12,401 shares (Common Stock) at a price of $3.61 per share, resulting in proceeds of $44,767. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 362K

3.02% 3M change

3.02% 12M change

Total Value Held $1.29 Million

KENNETH ERLAND JOHNSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2025	SELL Payment of exercise price or tax liability	$44,767 $3.61 p/Share	12,401 Reduced 3.31%	361,764 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$37,222 $2.46 p/Share	15,131 Reduced 3.9%	373,036 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	175,000 Added 28.14%	446,860 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$28,587 $2.66 p/Share	10,747 Reduced 2.69%	388,167 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$27,776 $2.24 p/Share	12,400 Reduced 3.01%	398,914 Common Stock
Jan 31 2023	SELL Payment of exercise price or tax liability	$4,207 $1.24 p/Share	3,393 Reduced 0.82%	411,314 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	100,000 Added 27.04%	269,783 Common Stock
Jan 29 2023	SELL Payment of exercise price or tax liability	$13,896 $1.26 p/Share	11,029 Reduced 2.59%	414,707 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$13,888 $1.12 p/Share	12,400 Reduced 2.83%	425,736 Common Stock
Jan 31 2022	SELL Payment of exercise price or tax liability	$4,867 $2.11 p/Share	2,307 Reduced 0.52%	438,136 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$15,818 $2.11 p/Share	7,497 Reduced 1.67%	440,443 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	75,000 Added 31.14%	165,865 Common Stock
Oct 05 2021	BUY Grant, award, or other acquisition	-	89,583 Added 50.0%	89,583 Common Stock

Also insider at

XERS

XERIS PHARMACEUTICALS INC Healthcare

Officer

KEJ